A203690 Stock Overview
Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Ark Solutions Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,080.00 |
| 52 Week High | ₩14,040.00 |
| 52 Week Low | ₩4,150.00 |
| Beta | 0.55 |
| 1 Month Change | 34.22% |
| 3 Month Change | 2.88% |
| 1 Year Change | -40.33% |
| 3 Year Change | -55.70% |
| 5 Year Change | -65.16% |
| Change since IPO | -80.36% |
Recent News & Updates
Ark Solutions Inc (KOSDAQ:203690) Surges 34% Yet Its Low P/S Is No Reason For Excitement
Dec 24
Ark Solutions (KOSDAQ:203690) Is Making Moderate Use Of Debt
Nov 28Recent updates
Ark Solutions Inc (KOSDAQ:203690) Surges 34% Yet Its Low P/S Is No Reason For Excitement
Dec 24Ark Solutions (KOSDAQ:203690) Is Making Moderate Use Of Debt
Nov 28Sphere Power (KOSDAQ:203690) Is Carrying A Fair Bit Of Debt
Jul 31Lacklustre Performance Is Driving Sphere Power Inc.'s (KOSDAQ:203690) 25% Price Drop
Jun 20Investors Don't See Light At End Of Sphere Power Inc.'s (KOSDAQ:203690) Tunnel And Push Stock Down 29%
May 06Further Upside For Sphere Power Inc. (KOSDAQ:203690) Shares Could Introduce Price Risks After 44% Bounce
Mar 21Sphere Power Inc. (KOSDAQ:203690) Soars 44% But It's A Story Of Risk Vs Reward
Mar 21Would Prostemics (KOSDAQ:203690) Be Better Off With Less Debt?
Apr 13What Type Of Returns Would Prostemics'(KOSDAQ:203690) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Feb 17
Do Institutions Own Prostemics Co., Ltd. (KOSDAQ:203690) Shares?
Dec 22Shareholder Returns
| A203690 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -1.9% | -1.2% | -0.9% |
| 1Y | -40.3% | 16.3% | -9.0% |
Return vs Industry: A203690 underperformed the KR Biotechs industry which returned 16.3% over the past year.
Return vs Market: A203690 underperformed the KR Market which returned -9% over the past year.
Price Volatility
| A203690 volatility | |
|---|---|
| A203690 Average Weekly Movement | 7.7% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A203690 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A203690's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 55 | Won-Jong Lee | www.prostemics.co.kr |
Ark Solutions Inc. engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally. It operates through Life and Health Business and Exosome Business divisions. The company offers products using stem cells.
Ark Solutions Inc Fundamentals Summary
| A203690 fundamental statistics | |
|---|---|
| Market cap | ₩80.08b |
| Earnings (TTM) | -₩22.97b |
| Revenue (TTM) | ₩32.66b |
2.5x
P/S Ratio-3.5x
P/E RatioIs A203690 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A203690 income statement (TTM) | |
|---|---|
| Revenue | ₩32.66b |
| Cost of Revenue | ₩33.04b |
| Gross Profit | -₩389.25m |
| Other Expenses | ₩22.58b |
| Earnings | -₩22.97b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.74k |
| Gross Margin | -1.19% |
| Net Profit Margin | -70.35% |
| Debt/Equity Ratio | 87.5% |
How did A203690 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 21:08 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ark Solutions Inc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|